Which of the following findings is typically NOT seen in a patient with allergic conjunctivitis?
A 12-year-old boy presents with recurrent attacks of conjunctivitis for the last 2 years, characterized by intense itching and ropy discharge. The diagnosis is likely to be:
Features of vernal conjunctivitis are:
Ramu, a 10-year-old patient, presents with itching in his eye, foreign body sensation, and ropy discharge since several months, with symptoms more prominent in summer. What is the most probable diagnosis?
Which of the following is a feature of vernal keratoconjunctivitis?
Which of the following is not true of acute conjunctivitis?
In chronic allergy, which Ig is more persistent in the body?
Which of the following is not a treatment option for vernal keratoconjunctivitis?
Which one of the following is a criterion of Kawasaki disease?
Which of the following is not a treatment for vernal keratoconjunctivitis?
Explanation: ***Purulent discharge*** - **Purulent discharge** (thick, yellowish, or greenish) is characteristic of **bacterial conjunctivitis** and is usually absent in allergic conjunctivitis. - Allergic conjunctivitis typically presents with a **clear or watery discharge**. *Watery discharge* - **Watery discharge** is a very common symptom of **allergic conjunctivitis**, often accompanied by itching and redness. - It results from the inflammatory response and increased lacrimation due to allergen exposure. *Itching* - **Ocular itching** is the hallmark symptom of allergic conjunctivitis and is considered its most distinctive feature. - It is caused by the release of **histamine** and other inflammatory mediators from mast cells in response to allergens. *Bilateral eye redness* - **Bilateral conjunctival redness** (hyperemia) is a frequent finding in allergic conjunctivitis. - This is due to **vasodilation** in response to the inflammatory process affecting both eyes, as airborne allergens often affect both simultaneously.
Explanation: ***Vernal conjunctivitis*** - **Vernal keratoconjunctivitis (VKC)**, commonly called **vernal conjunctivitis**, is a chronic, bilateral inflammation of the conjunctiva, most common in young boys, characterized by intense itching and thick, **ropy discharge**. - It is a **type 1 hypersensitivity reaction** and often exhibits seasonal recurrence, improving in colder months, which aligns with the "recurrent attacks for the last 2 years" given the patient's age. *Phlyctenular conjunctivitis* - **Phlyctenular conjunctivitis** is characterized by the formation of small, raised nodules (**phlyctenules**) on the conjunctiva or cornea, often associated with a delayed hypersensitivity response to bacterial antigens like **tuberculosis** or **Staphylococcus**. - It typically presents with **irritation**, **photophobia**, and **lacrimation**, but not the ropy discharge or predominant severe itching seen in this boy. *Viral conjunctivitis* - **Viral conjunctivitis** is highly contagious and often presents with **redness**, **watery discharge**, and sometimes an associated **upper respiratory infection**. - While it can cause itching and redness, the discharge is typically watery, not ropy, and the long-term recurrent nature with ropy discharge is less characteristic of viral etiologies. *Trachoma* - **Trachoma**, caused by **Chlamydia trachomatis**, is a chronic infectious eye disease leading to inflammation, follicular conjunctivitis, and ultimately scarring that can cause **blindness**. - It is prevalent in developing countries and typically presents with a mucopurulent discharge and characteristic follicles, but the intense itching and ropy discharge in a 12-year-old in a recurrent pattern are not its primary defining features.
Explanation: ***All of the options*** - **Vernal conjunctivitis (VKC)** is a severe form of allergic conjunctivitis characterized by chronic inflammation of the conjunctiva, impacting the cornea in advanced stages. - **Shield ulcers**, **Horner-Trantas dots**, and **papillary hypertrophy** are all classic clinical features observed in VKC. *Shield ulcer* - This is a **corneal complication** of severe vernal conjunctivitis, characterized by epithelial defects that can lead to significant pain and vision impairment. - It develops due to corneal abrasion from the giant papillae on the upper tarsal conjunctiva and direct corneal toxicity from inflammatory mediators. *Horner-Trantas spots* - These are **gelatinous aggregations** of epithelial cells and eosinophils that appear as white dots at the limbus, particularly evident at the superior limbus. - They are one of the **pathognomonic signs** of vernal conjunctivitis, indicating significant allergic inflammation. *Papillary hypertrophy* - Characterized by the development of **large, flattened papillae** (often described as "cobblestone" papillae) on the upper tarsal conjunctiva. - This hypertrophy is a result of chronic inflammation and proliferation of mast cells, eosinophils, and lymphocytes in the conjunctival stroma.
Explanation: ***Vernal conjunctivitis*** - **Vernal conjunctivitis** (or allergic conjunctivitis) is characterized by **itching**, foreign body sensation, and a **ropy, tenacious discharge**, which are all present in Ramu's case. - The symptoms are typically **seasonal**, often worsening during warmer months (summer), matching the patient's presentation. *Fungal keratoconjunctivitis* - This condition often presents with a history of **ocular trauma** involving vegetable matter or contact lens use, which is not mentioned here. - Clinical signs typically include a **corneal ulcer**, often with feathery margins and satellite lesions, alongside eye discomfort, rather than predominantly ropy discharge and itching. *Viral conjunctivitis* - Viral conjunctivitis typically presents with **watery discharge**, conjunctival hyperemia, and often a history of an **upper respiratory tract infection**. - While it can cause foreign body sensation and redness, the prominent **ropiness of the discharge** and **seasonal recurrence** described are less characteristic of viral etiology. *Trachoma* - Trachoma is a chronic infectious eye disease caused by *Chlamydia trachomatis*, leading to severe scarring of the conjunctiva and can cause blindness. - It is often associated with poor hygiene and crowded living conditions, and typically presents with **conjunctival scarring**, **trichiasis**, and potentially corneal opacities, which differ from Ramu's chronic allergic presentation.
Explanation: ***Papillary hypertrophy*** - This is a hallmark feature of **vernal keratoconjunctivitis (VKC)**, particularly the presence of large, **cobblestone papillae** on the upper tarsal conjunctiva. - The papillary reaction is due to inflammation and infiltration of the conjunctival stroma with lymphocytes, plasma cells, and eosinophils, leading to raised bumps. - VKC is a chronic, bilateral allergic condition typically affecting children and young adults, with seasonal exacerbations. *Follicular hypertrophy* - **Follicular hypertrophy** is characterized by dome-shaped, avascular elevations formed by hyperplasia of lymphoid tissue, commonly seen in **viral conjunctivitis** and **chlamydial conjunctivitis**. - It is not typically seen in VKC, which is an allergic condition with a papillary rather than follicular response. *Pseudomembrane formation* - **Pseudomembrane formation** is a coagulum of inflammatory exudates and necrotic epithelial cells that loosely adheres to the conjunctiva and can be peeled off without bleeding, often seen in severe **adenoviral conjunctivitis**. - This feature is not characteristic of vernal keratoconjunctivitis. *Membrane formation* - **True membrane formation** involves a fibrinous exudate that is firmly adherent to the conjunctiva, and removal causes bleeding. It is seen in **bacterial conjunctivitis** (particularly diphtheria) and **Stevens-Johnson syndrome**. - Unlike papillary hypertrophy in VKC, membrane formation represents severe inflammatory or infectious processes.
Explanation: ***Topical antibiotics are the mainstay of treatment*** - This is **NOT true** because **viral conjunctivitis** accounts for approximately **80% of acute conjunctivitis cases** and **does not respond to antibiotics**. - Most acute conjunctivitis is **self-limiting** and resolves spontaneously within 1-2 weeks. - **Bacterial conjunctivitis** may benefit from topical antibiotics, but they are not the "mainstay" since most cases are viral. - Treatment focus should be on supportive care, cool compresses, and artificial tears. *Vision is not affected* - This statement **is true**; acute conjunctivitis primarily affects the **conjunctiva** and typically **does not impair visual acuity**. - Vision remains **normal** in uncomplicated cases. - Any significant vision loss would suggest **keratitis**, **uveitis**, or other more serious conditions. *Corneal infiltration occurs* - This statement **is generally true** for certain types of viral conjunctivitis, particularly **epidemic keratoconjunctivitis (EKC)** caused by adenovirus. - **Subepithelial infiltrates** can develop in the cornea, especially 1-2 weeks after onset, causing decreased vision and foreign body sensation. - However, in simple acute bacterial conjunctivitis, corneal involvement is uncommon unless it progresses to keratoconjunctivitis. *Pupil remains unaffected* - This statement **is true**; the pupil's size and reactivity are governed by the iris and ciliary body, which are **not involved** in conjunctivitis. - Any pupillary abnormalities (irregular pupil, poor reaction) would indicate **anterior uveitis** or **intraocular inflammation**, not simple conjunctivitis.
Explanation: ***Ig E*** - **IgE** is the primary antibody involved in **allergic reactions**, binding to receptors on **mast cells** and **basophils** to trigger histamine release. - In chronic allergy, sustained exposure to allergens leads to continuous production of IgE, making it a **persistent** and dominant immunoglobulin in the allergic response. *Ig A* - **IgA** is mainly found in **mucosal secretions**, such as tears, saliva, and gut, protecting against pathogens at these sites. - While important for immunity, IgA does not play a direct role in the **immediate hypersensitivity reactions** characteristic of chronic allergies. *Ig G* - **IgG** is the most abundant antibody in serum, providing **long-term immunity** against pathogens through neutralization, opsonization, and complement activation. - Though present, IgG is not the **primary mediator** of the **allergic response** in chronic allergy, instead often associated with protective immunity or certain non-IgE mediated hypersensitivities. *Ig M* - **IgM** is the first antibody produced during a **primary immune response** and is effective at activating the complement system. - It is predominantly found in the bloodstream and functions as a **short-term defender**, but it is not directly involved in the pathogenesis or persistence of chronic allergies.
Explanation: ***Antibiotics*** - **Vernal keratoconjunctivitis (VKC)** is a non-infectious, **allergic inflammatory condition** of the conjunctiva. - Antibiotics are primarily used to treat bacterial infections and have **no direct role** in the management of VKC. *Steroids* - **Topical corticosteroids** (e.g., prednisolone, loteprednol, fluorometholone) are a mainstay of VKC treatment, especially for severe cases and acute exacerbations. - They significantly reduce inflammation and associated symptoms by **suppressing the immune response**. *Chromaglycate* - **Sodium cromoglycate** is a **mast cell stabilizer** commonly used in the treatment of VKC. - It works by preventing the degranulation of mast cells, thereby **inhibiting the release of inflammatory mediators** like histamine. *Olopatadine* - **Olopatadine** is a dual-acting medication that functions as both an **antihistamine** and a **mast cell stabilizer**. - It provides rapid relief from itching and other allergic symptoms by blocking histamine receptors and stabilizing mast cells.
Explanation: ***Rash*** - A **polymorphous rash**, which can be macular, papular, or scarlatiniform, is one of the **five principal diagnostic criteria** for **Kawasaki disease**. - This rash typically appears early in the course of the illness and can affect any part of the body, often involving the trunk and extremities. *Edema* - **Edema of the hands and feet**, especially when accompanied by **erythema** (redness), is actually one of the **principal diagnostic criteria** for Kawasaki disease under "extremity changes." - This finding typically occurs in the acute phase, followed by **desquamation** (peeling) in the convalescent phase, particularly in the periungual region. - Note: While edema is a valid criterion, **rash** is considered the most characteristic and commonly used criterion among the options listed. *Purulent conjunctivitis* - **Kawasaki disease** characteristically presents with **bilateral non-purulent (non-exudative) conjunctival injection** - red eyes without discharge or exudate. - **Purulent conjunctivitis** (conjunctivitis with pus/discharge) indicates a bacterial infection and actually argues **against** the diagnosis of Kawasaki disease. - This is the only option that is definitively **not** a criterion. *Strawberry tongue* - **Strawberry tongue** (red, swollen tongue with prominent papillae) is part of the **oral changes criterion** in Kawasaki disease, which includes red cracked lips, strawberry tongue, and erythema of the oropharyngeal mucosa. - While also seen in scarlet fever and toxic shock syndrome, strawberry tongue is a **recognized feature** of Kawasaki disease. - Note: This is technically a valid criterion, though less specific than the polymorphous rash.
Explanation: ***Antibiotics*** - **Vernal keratoconjunctivitis (VKC)** is an **allergic inflammatory condition**, not a bacterial infection, making antibiotics ineffective for its primary treatment. - While secondary bacterial infections can occur, antibiotics are not a first-line or primary treatment for the underlying allergic inflammation of VKC. *Steroids* - **Steroids**, especially topical corticosteroids, are highly effective in managing acute exacerbations and severe inflammation in VKC due to their potent anti-inflammatory effects. - Long-term use requires careful monitoring due to potential side effects like **cataracts** and **glaucoma**. *Chromoglycate* - **Cromolyn sodium (chromoglycate)** is a **mast cell stabilizer** that prevents the release of inflammatory mediators, thus helping to manage chronic allergic symptoms in VKC. - It is often used as a **preventative measure** or for maintenance therapy, not for acute flares. *Olopatadine* - **Olopatadine** is a dual-acting medication that functions as both an **antihistamine** and a **mast cell stabilizer**, making it effective in reducing allergic symptoms like itching and redness in VKC. - It is commonly used for symptomatic relief in allergic conjunctivitis conditions, including VKC.
Get full access to all questions, explanations, and performance tracking.
Start For Free